Sort
15,842 grants matching “pancreatic cancer”
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome
$263,700Jing Chen · Emory University · R01 · FY2008 · CA
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome
$263,700Jing Chen · Emory University · R01 · FY2009 · CA
Refined Fructose Promotes Pancreatic Cancer Growth
$263,340Anthony P Heaney · University Of California Los Angeles · R01 · FY2007 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER
$263,248Dartmouth College · R01 · FY2004 · CA
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer
$263,224Suresh T. Chari · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · DK
Preclinical Therapeutics
$263,196Frank Patrick McCormick · University Of California, San Francisco · P30 · FY2014 · CA
Studies on the Post-translational processing of MUC1
$263,177Michael A Hollingsworth · University Of Nebraska Medical Center · R01 · FY2009 · CA
Studies on the Post-translational processing of MUC1
$263,177Michael A Hollingsworth · University Of Nebraska Medical Center · R01 · FY2010 · CA
Studies on the Post-translational processing of MUC1
$263,177Michael A Hollingsworth · University Of Nebraska Medical Center · R01 · FY2008 · CA
GABA-B-R-mediated prevention of pancreatic cancer
$263,148Hildegard Schuller · University Of Tennessee Knoxville · R01 · FY2013 · CA
Pharmacologic /Genetic Inhibition of XBP1 as Hypoxia Targeted Therapeutic Strateg
$263,139Albert Koong · Stanford University · P01 · FY2009 · CA
Multiparametric endoscopic ultrasound for improved pancreatic cancer screening and characterization
$263,086Mark Thomas Burgess · Sloan-Kettering Inst Can Research · R21 · FY2025 · CA
Cancer Biology Training Program
$262,981Jennifer D Black · University Of Nebraska Medical Center · T32 · FY2025 · CA
Pharmacodiagnotics through Molecular Clues
$262,958Scott E Kern · Johns Hopkins University · P50 · FY2010 · CA
The role of gut microbe-derived choline metabolites in driving the pro-inflammatory macrophage phenotype and restricting pancreatic cancer
$262,871Rahul Suresh Shinde · Wistar Institute · R21 · FY2021 · CA
GLYCOCONJUGATES IN PANCREATIC CANCER
$262,767Northern California Institute Res &Educ · R01 · FY2000 · CA
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
$262,723Richard Andrew Burkhart · Johns Hopkins University · K08 · FY2021 · CA
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
$262,723Richard Andrew Burkhart · Johns Hopkins University · K08 · FY2022 · CA
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
$262,723Richard Andrew Burkhart · Johns Hopkins University · K08 · FY2023 · CA
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
$262,723Richard Andrew Burkhart · Johns Hopkins University · K08 · FY2020 · CA
Personalized preclinical models in pancreas cancer: a tractable approach to precision medicine
$262,723Richard Andrew Burkhart · Johns Hopkins University · K08 · FY2024 · CA
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer
$262,683Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2018 · CA
Molecular Analysis of Ras Oncogene Activated Gene Expres
$262,550Ohio State University · R01 · FY2005 · CA
Molecular Analysis of Ras Oncogene Activated Gene Expres
$262,550Ohio State University · R01 · FY2004 · CA
Molecular Analysis of Ras Oncogene Activated Gene Expres
$262,550Ohio State University · R01 · FY2003 · CA